维普中文期刊产品整合服务

Impact of conditioning regimen on peripheral blood hematopoietic cell transplant

查看全文 作  者:Michael [1]Burns;Anurag K [2]Singh;Carrie C [1]Hoefer;Yali [1]Zhang;Paul K [3]Wallace;George L [1]Chen;Alexis [2]Platek;Timothy B [2]Winslow;Austin J [2]Iovoli;Christopher [4]Choi;Maureen [1]Ross;Philip L [1]McCarthy;Theresa [1]Hahn 高影响力作者 机构地区:[1]Department of Medicine, Roswell Park Comprehensive Cancer Center;[2]Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center;[3]Department of Flow Cytometry, Roswell Park Comprehensive Cancer Center;[4]Center for Immunotherapy, Roswell Park Comprehensive Cancer Center高影响力机构 出  处:《World Journal of Clinical Oncology》索引2019年第10卷第2期,共12页高影响力期刊 摘  要:AIM To investigate infused hematopoietic cell doses and their interaction with conditioning regimen intensity +/-total body irradiation(TBI) on outcomes after peripheral blood hematopoietic cell transplant(PBHCT).METHODS Our retrospective cohort included 247 patients receiving a first, T-replete, human leukocyte antigen-matched allogeneic PBHCT and treated between 2001 and2012. Correlations were calculated using the Pearson product-moment correlation coefficient. Overall survival and progression free survival curves were generated using the Kaplan-Meier method and compared using the log-rank test.RESULTS Neutrophil engraftment was significantly faster after reduced intensity TBI based conditioning [reduced intensity conditioning(RIC) + TBI] and > 4 × 10~6 CD34+cells/kg infused. A higher total nucleated cell dose led to a higher incidence of grade II-IV acute graft-versus-host disease in the myeloablative + TBI regimen group(P = 0.03), but no significant difference in grade III-IV graft-versus-host disease. A higher total nucleated cell dose was also associated with increased incidence of moderate/severe chronic graft-versus-host disease, regardless ofconditioning regimen. Overall and progression-free survival were significantly better in patients with a RIC + TBI regimen and total nucleated cell dose > 8 ×10~8/kg(3 years, overall survival: 70% vs 38%, P = 0.02, 3 years, progression free survival: 64% vs 38%, P = 0.02).CONCLUSION TBI and conditioning intensity may alter the relationship between infused cell doses and outcomes after PBHCT. Immune cell subsets may predict improved survival after unmanipulated PBHCT. 关 键 词:TOTAL body radiation Peripheral blood HEMATOPOIETIC cell TRANSPLANT TOTAL nucleated dose NEUTROPHIL ENGRAFTMENT GRAFT-VERSUS-HOST-DISEASE
相关文献

参考文献(30)

引证文献(1)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费